Navigation Links
Poniard Pharmaceuticals Reports First Quarter 2009 Financial Results and Provides a Corporate Update
Date:5/5/2009

mated 49,960 deaths (American Cancer Society, Cancer Facts and Figures 2009). The current standard of care is associated with significant side effects including neuropathy, which can limit its use and result in its discontinuation. Effective first-line, neuropathy sparing treatment for CRC is a major unmet medical need.

About Prostate Cancer

More than 1 million American men are currently living with prostate cancer and it is the second leading cause of death among men in the U.S. In 2008, an estimated 186,320 new cases of prostate cancer were expected to be diagnosed in the U.S., with an estimated 28,660 deaths (American Cancer Society, Cancer Facts and Figures 2009). CRPC is prostate cancer that continues to grow despite current standard of care hormonal (anti-androgen) therapies. CRPC is more invasive and more likely to spread to other organs than androgen dependent prostate cancers. Patients with CRPC have few treatment options and a poor prognosis.

About Picoplatin

Picoplatin is designed to overcome platinum resistance associated with chemotherapy in solid tumors. Study data to date suggest that it has an improved safety profile relative to existing platinum-based cancer therapies. More than 1,100 patients have received picoplatin. Results obtained to date suggest manageable hematologic adverse events with less severe kidney toxicity (nephrotoxicity) and nerve toxicity (neurotoxicity) than is commonly observed with other platinum chemotherapy drugs. Picoplatin has demonstrated anti-tumor activity in a variety of solid tumors. It is being studied in multiple cancer indications, treatment combinations and by two routes of administration.

Conference Call Details

Poniard's management team will host a live conference call and Webcast today at 5:00 p.m. Eastern Time/2:00 p.m. Pacific Time. To participate by telephone, please di
'/>"/>

SOURCE Poniard Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
2. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
3. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
4. Poniard Pharmaceuticals Initiates Randomized Phase 2 Trial of Picoplatin for First-Line Treatment of Metastatic Colorectal Cancer
5. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
6. Poniard Pharmaceuticals Announces Picoplatin Safety Data in Colorectal Cancer
7. Poniard Pharmaceuticals Announces Positive First-line Phase 1 Safety and Efficacy Data With Picoplatin in Metastatic Prostate Cancer Patients
8. Poniard Pharmaceuticals Announces Clinical Data From Picoplatin Oral Phase 1 to Be Presented at the American Association of Cancer Research Annual Meeting
9. Poniard Pharmaceuticals Announces Commercial Manufacturing Agreement With W. C. Heraeus GmbH for Picoplatin
10. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
11. Poniard Pharmaceuticals Oral Picoplatin Demonstrates Positive Bioavailability in Ongoing Phase 1 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... CHICAGO , May 21, 2015 /PRNewswire-USNewswire/ ... lump along the side of his neck, ... and took a couple weeks off from ... didn,t go away.                               ... Rendino, 26, was referred to Michel ...
(Date:5/21/2015)... May 21, 2015 ... announced the addition of the "Arthroscopy ... offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The purpose ... size the world market for Arthroscopy Devices. ... trends impacting the market for these products. ...
(Date:5/21/2015)... ANDOVER, Mass. , May 21, 2015 /PRNewswire/ ... into the Electronic Health Record (EHR) is invaluable ... ICU. Though EHRs are now a requirement and ... to and continuously into the EHR is gaining ... Software Exchange), William Holmes, RN, Site Project Manager ...
Breaking Medicine Technology:Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4Analysing Arthroscopy Devices Markets Worldwide 2014-2020 2Analysing Arthroscopy Devices Markets Worldwide 2014-2020 3Hospital Streamlines ICU Efficiency with Timely Data Integration 2Hospital Streamlines ICU Efficiency with Timely Data Integration 3
... Raptor Pharmaceutical Corp. (Nasdaq: RPTP ), today announced ... Company,s orally administered non-opioid, AMPA/kainate antagonist, will be presented ... Treatment of Neuropathic Pain, to be held November 20-21, ... ) , Mark Wallace, M.D., Professor of ...
... Varian, Inc. (NasdaqGS: VARI) today reported fourth quarter fiscal ... from the fourth quarter of fiscal year 2008. Orders ... of fiscal year 2009. , Non-GAAP (adjusted) diluted earnings per ... decrease of 48.7% from the $0.78 in the fourth quarter ...
Cached Medicine Technology:Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference 2Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference 3Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference 4Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference 5Varian, Inc. Reports Fourth Quarter 2009 Results 2Varian, Inc. Reports Fourth Quarter 2009 Results 3Varian, Inc. Reports Fourth Quarter 2009 Results 4Varian, Inc. Reports Fourth Quarter 2009 Results 5Varian, Inc. Reports Fourth Quarter 2009 Results 6Varian, Inc. Reports Fourth Quarter 2009 Results 7Varian, Inc. Reports Fourth Quarter 2009 Results 8Varian, Inc. Reports Fourth Quarter 2009 Results 9Varian, Inc. Reports Fourth Quarter 2009 Results 10Varian, Inc. Reports Fourth Quarter 2009 Results 11Varian, Inc. Reports Fourth Quarter 2009 Results 12Varian, Inc. Reports Fourth Quarter 2009 Results 13Varian, Inc. Reports Fourth Quarter 2009 Results 14Varian, Inc. Reports Fourth Quarter 2009 Results 15Varian, Inc. Reports Fourth Quarter 2009 Results 16Varian, Inc. Reports Fourth Quarter 2009 Results 17Varian, Inc. Reports Fourth Quarter 2009 Results 18Varian, Inc. Reports Fourth Quarter 2009 Results 19Varian, Inc. Reports Fourth Quarter 2009 Results 20Varian, Inc. Reports Fourth Quarter 2009 Results 21Varian, Inc. Reports Fourth Quarter 2009 Results 22
(Date:5/22/2015)... 22, 2015 Steven Winter Associates (SWA) ... has been selected by Consulting-Specifying Engineer (CSE) magazine as ... are featured in the May/June issue of the publication. ... professionals age 40 and younger who have, and continue ... well as in other areas of their professional and ...
(Date:5/22/2015)... Anaheim, Calif. (PRWEB) May 22, 2015 ... newly opened Anaheim Fit Body Boot Camp, recently accepted ... milestone so quickly after the launch of his location ... upon the Anaheim community. , Fit Body Boot Camp ... fitness boot camp franchise with hundreds of locations across ...
(Date:5/22/2015)... WI (PRWEB) May 22, 2015 ... honor to be recognized for providing the highest quality ... foundation of health care decision-making,” said Javon R. Bea, ... demonstrates the commitment of our employee/partners to care for ... patients.” , Hospitals do not apply for this award, ...
(Date:5/21/2015)... 21, 2015 Her popular Love Seminar will ... Hotel in San Gabriel on Saturday, May 23rd. , ... from men and women who are unhappy in their relationships ... , "Many singles think that their biggest problem is not ... go from one relationship to another trying to find the ...
(Date:5/21/2015)... Nashville, TN (PRWEB) May 21, 2015 Ticket Down ... soccer match featuring USA vs. Guatemala on Friday, July ... time is now to become a fan of international soccer. The ... the world play on American soil is growing at a large ... worldwide teams have come to the USA to play in front ...
Breaking Medicine News(10 mins):Health News:Steven Winter Associates’ Marc Zuluaga Earns Innovative Engineering Award 2Health News:Healthy Living Brought to Anaheim— New Fitness Boot Camp Acquires 100 Clients 2Health News:Mercy Hospital and Trauma Center Receives Women’s Choice Award for Emergency Care - Mercy Health System Javon Bea 2Health News:Bestselling Author Sheds Light on Why Modern Dating is Hurting People's Chances of Finding a Lasting Relationship 2Health News:USA vs. Guatemala Tickets: Ticket Down Slashes United States Men's Soccer Team (USMNT) vs. Guatemala Tickets at LP Field in Nashville on 7/3/15 2
... not prevent future aggressive gastric lymphoma since resting B ... led by Dr. Anne Mueller at Stanford University // ... al., "The role of antigenic drive and tumor-infiltrating accessory ... in the September issue of The American Journal of ...
... research report, by researchers from National Institute of Child Health ... suggest that a drug used for reducing the risk of ... an alternative to conducting surgery after a miscarriage., ,The ... of Medicine. , ,The drug, misoprostol, has been used ...
... A recent study has focused on the communication processes between ... of damaged cells, leading to blindness. , ,Normally cells ... cell to the other, enabling communication. For cells that don't ... which enables movement of molecules to and fro in the ...
... Researchers from HHS’ Agency for Healthcare Research and Quality ... may have been overrated, as the reported health benefits ... of soy protein found in tofu // and other ... low-density lipoprotein (LDL, known as bad cholesterol) and triglyceride ...
... adults. TB is a lung disease, caused by a ... with TB somewhere in the world every second. //, ... available which, however, fails to protect against the most ... multi-drug-resistant tuberculosis strains are on the rise, which cannot ...
... attuned to the care of his patients that he loses ... himself while doing so. A recent study has reported poor ... UK, supporting the above-mentioned statement. , ,Over 800 consultants ... was found among the respondents who belonged to gastroenterology, radiology, ...
Cached Medicine News:Health News:Helicobacter pylori Antibiotic Treatment of Peptic Ulcer May not Prevent Gastric lymphomas 2Health News:Drugs As Alternative To Surgery After Miscarriage 2Health News:Soy Benefits May Not Be As Much As Thought Before 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: